image description

Krishna Veeraraghavan


Krishna Veeraraghavan

New York +1-212-558-4000+1-212-558-4000 +1-212-558-3588+1-212-558-3588
veera[email protected]
Recognized as “Dealmaker of the Year” in 2018 and twice named “Dealmaker of the Week” by The American Lawyer, Krishna Veeraraghavan is a partner and member of S&C’s Mergers and Acquisitions Group. Mr. Veeraraghavan has a broad multidisciplinary practice that includes extensive experience in mergers and acquisitions and corporate governance. He has been engaged in many high profile matters that include activism, cross-border transactions, leveraged buyouts, proxy contests and unsolicited bids as an adviser to global leaders such as, AB InBev, AT&T, BHP Billiton, CA Technologies, Praxair and Teva Pharmaceuticals. Mr. Veeraraghavan also regularly counsels boards of directors and board committees on corporate governance, crisis management and matters affecting corporate policy and strategy. He is an adjunct professor at Columbia Law School. Over the past several years he has advised on a variety of matters including:

Healthcare & Life Sciences
  • Seattle Genetics in its $614 million acquisition of Cascadian Therapeutics
  • Syneos Health in its $7.4 billion merger of equals with inVentiv Health
  • Stemcentrx in its $9.8 billion acquisition by AbbVie
  • Teva in its $40.5 billion acquisition of Allergan and $50.5 billion unsolicited proposal for Mylan, later withdrawn
  • Dyax in its $5.9 billion acquisition by Shire
  • Concordia Healthcare in its $3.5 billion acquisition of Amdipharm Mercury and $1.2 billion acquisition of all commercial assets of Covis
  • Synageva in its $8.4 billion acquisition by Alexion
  • Cyberonics in its $1.5 billion merger with Sorin to create LivaNova
  • LabCorp in its $6.1 billion acquisition of Covance
  • Idenix in its $3.85 billion acquisition by Merck
  • Perrigo in its $8.6 billion acquisition of Elan Pharmaceuticals
  • Concho Resources in its $9.5 billion acquisition of RSP Permian
  • Andeavor in the merger of Andeavor Logistics and Western Refining Logistics for $1.8 billion and the repositioning of Andeavor Logistics through an IDR buy-in valued at $4 billion
  • Cheniere Energy in its proposal to the board of directors of Cheniere Energy Partners to acquire Cheniere Energy Partners
  • BHP Billiton in its $15.1 billion acquisition of Petrohawk Energy
Consumer & Retail and Industrials
  • General Cable in its $3 billion acquisition by Prysmian Group
  • in its $13.7 billion acquisition of Whole Foods
  • Praxair in its $73 billion pending merger with Linde
  • Lion Capital in its acquisition of a minority interest in Authentic Brands; acquisition of Spence Diamonds; and $1.5 billion sale of Bumble Bee Foods to Thai Union Frozen Products, later withdrawn
  • Standard Industries in its $2.1 billion acquisition of Braas Monier; $1.1 billion acquisition of Icopal; and acquisition of Quest Construction Products
  • AB InBev in its $123 billion merger with SABMiller and $20.1 billion acquisition of the remaining stake in Grupo Modelo
  • Genesis Robotics in its strategic, controlling investment from Koch Chemical Technology Group, a unit of Koch Industries
  • in its pending agreement with Plug Power to utilize Plug Power fuel cells and hydrogen technology in its fulfillment network
  • Special Committee of Solera Holdings in connection with its $6.5 billion acquisition by Vista Equity Partners
Real Estate
  • Forest City Realty Trust in its agreement with Starboard Value to reconstitute of its Board of Directors
  • American Casino & Entertainment Properties in its $850 million acquisition by Golden Entertainment
  • Special Committee of Forest City Realty Trust in connection with the company's agreement to declassify its common stock and its settlement with Scopia Capital


Mr. Veeraraghavan is consistently recognized as a leading adviser by Chambers USA, Legal 500 and New York Super Lawyers. Recent accolades include:
  • “Dealmaker of the Year” by The American Lawyer – Amazon’s acquisition of Whole Foods (2018)
  • “Retail & E-Commerce MVP” by Law360 (2017)
  • “Life Sciences MVP” by Law360 (2015 & 2016)
  • “Transatlantic Rising Star” by The American Lawyer (2016)
  • “Dealmaker of the Week” by The American Lawyer – LabCorp’s acquisition of Covance (2015)
  • “Rising Star” by Law360 (2014) and New York Law Journal (2015)
  • “Highly Regarded Lawyer” by IFLR1000
  • “Dealmaker of the Week” by The American Lawyer – Synageva BioPharma’s acquisition by Alexion Pharmaceuticals (2014)
  • Empire State Counsel Honoree for Pro bono Service by the New York State Bar Association (2014)
  • Named among the “Best Lawyers Under 40” by The M&A Advisor (2012) and the National Asian Pacific American Bar Association (2014)
  • Finalist for “Legal Advisor of the Year” by The M&A Advisor (2013)
  • One of four “Rising Stars” (2013) by the Minority Corporate Counsel Association
In addition to being an adjunct professor, Mr. Veeraraghavan is a member of the Steering Committee of the Board of Visitors at Columbia Law School and is on the advisory board for the school’s Blue Sky Blog. Mr. Veeraraghavan is a member of the American Bar Association’s Committee on Mergers and Acquisitions and holds several board memberships, including the American India Foundation and South Asian Youth Action. In 2013, he was named a Fellow by the Leadership Council on Legal Diversity.